Aldevron is an American biotechnology company based in Fargo, North Dakota. It is a subsidiary of Danaher.[1]
History
Aldevron was an exhibitor at the 14th Annual Meeting of the American Society of Gene & Cell Therapy from May 18-21, 2011.[2]
COVID-19
On June 17, 2021, Danaher announced that it would acquire Aldevron.[3]
Organization
Aldevron is a member of the Medical CBRN Defense Consortium[4] and the Rapid Response Partnership Vehicle (RRPV) Consortium.[5]
Aldevron has been a client of Biotech Primer.[6]
External links
Business Directory. Danaher. Retrieved October 26, 2026, from https://www.danaher.com/business-directory ↩︎
Carter, B. J. (2011). 14th Annual Meeting - Final Program. American Society of Gene & Cell Therapy. https://web.archive.org/web/20150226065847/http://www.asgct.org/am11/AM11_Final_Program.pdf ↩︎
Danaher to acquire Aldevron. (2021, June 17). Danaher Corporation. https://investors.danaher.com/2021-06-17-Danaher-To-Acquire-Aldevron ↩︎
Current Members. MCDC. Retrieved January 3, 2023, from http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/ ↩︎
Current Members. Rapid Response Partnership Vehicle (RRPV). Retrieved January 19, 2025, from https://www.rrpv.org/current-members/ ↩︎
Life Science Training for Non-Scientists. Biotech Primer Inc. Retrieved April 18, 2026, from https://biotechprimer.com/about-biotech-primer/ ↩︎
